Symbols

XRTX

XORTX Therapeutics·NASDAQ

--(--)

7.21 / 10

Outperform

Analyst coverage is absent, but fund‑flow sentiment is strong (7.21/10) with positive inflows across all size categories. Capital is flowing in, supporting the stock despite the lack of analyst guidance.

Fund Flow Rating

What is the analyst consensus for XRTX?

XRTX holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.21/10 (Outperform).